Compile Data Set for Download or QSAR
maximum 50k data
Found 286 Enz. Inhib. hit(s) with all data for entry = 744
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM38065(4-chloro-3-(3-(4-chloro-3-methylphenoxy)propyl)-N-...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM38066(4-chloro-3-(3-(4-chloro-3,5-dimethylphenoxy)propyl...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM38101(3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-7-(3,5-...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM50160000(CHEMBL3786018 | US10093640, Example 89 | US1084403...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM38103(3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-7-(4-me...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM38104(3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-N-(phen...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM38109(3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-7-(2-me...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM38110(3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-7-(3-me...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM38112(3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-7-(1-me...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM38114(3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-7-(1-me...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM38115(3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-N-(phen...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM38119(3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-N-(phen...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM38120(3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-N-(phen...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM38131(4-bromo-3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM38134(3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-4-methy...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM38141(6-chloro-3-(3-(4-chloro-3,5-dimethylphenoxy)propyl...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM38143(3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-7-(1-me...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM38144(7-(3-((4-(4-acetylpiperazin-1-yl)phenoxy)methyl)-1...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM38147(3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-7-(3-(h...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM38150(3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-7-(3-(m...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM38201(33-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-N-((2-...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM286515(3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-7-(3-(h...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM286516(3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-N-((2-(...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM286517(3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-7-(3-(h...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM286518(N-((2-(1-benzyl-1H-pyrrole-2-carboxamido)ethyl)sul...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM50159949(CHEMBL3787178 | US10093640, Example 216 | US108440...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM50160018(CHEMBL3785155 | US10093640, Example 226 | US108440...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM289018(6-chloro-3-(3-(4-chloro-3,5-dimethylphenoxy)propyl...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM50159933(CHEMBL3786092 | US10093640, Example 232 | US108440...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM289022(6-chloro-3-(3-(4-chloro-3,5-dimethylphenoxy)propyl...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM50159954(CHEMBL3785998 | US10093640, Example 237 | US108440...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM50159945(CHEMBL3785666 | US10093640, Example 253 | US108440...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM50159940(CHEMBL3785228 | US10093640, Example 255 | US108440...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM289051(-chloro-3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM289052(5-(N-(6-chloro-3-(3-(4-chloro-3,5-dimethylphenoxy)...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM289055(US10093640, Example 264 | US10844032, Example 264 ...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM289058(5-(N-(6-chloro-3-(3-(4-chloro-3,5-dimethylphenoxy)...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM289071(3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-N-((2-(...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM289072(3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-7-(7-me...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM289075(3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-7-(7-me...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM289076(3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-7-(2-me...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM289078(3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-7-(1-et...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM289079(3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-N-(phen...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM289080(3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-7-(1-is...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM50160010(CHEMBL3786147 | US10093640, Example 305 | US108440...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM289082(3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-7-(1,5-...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM289083(3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-7-(1,5-...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM289084(3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-7-(3-((...)
Affinity DataIC50: <100nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM50424725(CHEMBL2314177 | US10093640, Example 5 | US10844032...)
Affinity DataIC50:  120nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM289038(6-chloro-3-(3-(4-chloro-3,5-dimethylphenoxy)propyl...)
Affinity DataIC50:  200nMpH: 7.5 T: 2°CAssay Description:Compound affinity was measured using a fluorescence polarization anisotropy competition assay. Anisotropy measurements were carried out in 384-well, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 286 total ) | Next | Last >>
Jump to: